Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)
NCT06114004
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma,Soft Tissue
Interventions
DRUG:
Selinexor 20 MG
DRUG:
Gemcitabine
Sponsor
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas